Inventor
ZUPANCIC THOMAS JOEL
US17 patents
⚠️ This page may combine multiple inventors who share the name “ZUPANCIC THOMAS JOEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROGENITOR INC
10 patentsUS5643748AJul 1, 1997
HU-B1.219, a novel human hematopoietin receptor
PROGENITOR INC54 citations95
US5877281AMar 2, 1999
Developmentally-regulated endothelial cell locus-1
PROGENITOR INC17 citations91
US5869610AFeb 9, 1999
Hu-B1.219, a novel human hematopoietin receptor
PROGENITOR INC18 citations91
US5856098AJan 5, 1999
Detection of a leptin receptor variant
PROGENITOR INC26 citations91
US5763211AJun 9, 1998
Isolated nucleic acid encoding Hu-B1.219, a novel human hematopoietin
PROGENITOR INC23 citations91
US6005080ADec 21, 1999
Antibodies specific for Hu-B1.219, a novel hematopoietin receptor
PROGENITOR INC16 citations81
US6355237B1Mar 12, 2002
Methods for using the obese gene and its gene product to stimulate hematopoietic development
PROGENITOR INC10 citations72
US5912123AJun 15, 1999
Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
PROGENITOR INC15 citations72
US5882860AMar 16, 1999
Detection of a leptin receptor variant and methods for regulating obesity
PROGENITOR INC16 citations72
US5874562AFeb 23, 1999
Nucleic acid encoding developmentally-regulated endothelial cell locus-1
PROGENITOR INC7 citations68
INDEVUS PHARMACEUTICALS INC
3 patentsUS6953670B2Oct 11, 2005
Methods for identifying compounds capable of supplementing the biological activity of leptin
INDEVUS PHARMACEUTICALS INC0 citations51
US6838079B2Jan 4, 2005
Methods for using the obese product to stimulate hematopoietic development
INDEVUS PHARMACEUTICALS INC0 citations51
US6524806B1Feb 25, 2003
Methods of screening for ligands of human hemetopoietin receptor HU-B1.219
INDEVUS PHARMACEUTICALS INC0 citations51